Table 5. Comparison of BCVA among nepafenac and ketorolac groups.
BCVA | Nepafenac group (n=20) | Ketorolac group(n=20) | Test of significance |
Preoperative | 1.0 (0.6-1.5) | 1.1 (0.6-1.5) | Z=1.04; P=0.32 |
1wk postop. | 0.3 (0.2-0.8) | 0.3 (0.2-0.6) | Z=1.05; P=0.29 |
1mo postop. | 0.2 (0.0-0.6) | 0.3 (0.0-0.6) | Z=1.5; P=0.13 |
2mo postop. | 0.0 (0.0-0.3) | 0.25 (0.0-0.6) | Z=1.92; P=0.055 |
3mo postop. | 0.0 (0.0-0.2) | 0.0 (0.0-0.3) | Z=1.36; P=0.17 |
median (min-max), logMAR